Health House International

15/06/2022

Can medicinal cannabis be used to help children with autism in Australia? – Read full article here

While relieved parents have welcomed the change in their children’s behaviour, some obstacles to the treatment remain.

08/06/2022

Health House growth in cash receipts was mainly due to strong sales in Australia and the United Kingdom as well as Germany starting to scale.
$HHI

31/05/2022

$HHI

25/05/2022

Health House International, Australia´s first importer of medicinal cannabis, has become a market leading distributor with 17 manufacturers´ products sold through digital platform providing 24hr delivery to pharmacies $HHI

19/05/2022

The Health House team is looking forward to attending the United in Compassion 2022 Medicinal Cannabis Symposium in the Sunshine Coast this weekend. The key speakers include Olivia Newton-John, Dr. Sue Sisley, Professor Dedi Meiri, and a special presentation from Professor Raphael Mechoulam via Israel.

02/05/2022

ASX Announcement: March 2022 Quarterly Report. Read full announcement here http://ow.ly/fXmL50IWHrG

29/03/2022

CanPharma has continued its strategy to enter into preferred supplier agreements with German statutory health insurance funds.

24/03/2022

Health House Chief Executive Officer, David Attwood commenting on the new CanPharma medicinal cannabis supply agreements with German statutory health insurance funds

24/03/2022

CanPharma Chief Executive Officer, and Health House Executive Director, Dr Henrik Sprengel commenting on the new CanPharma medicinal cannabis supply agreements with German statutory health insurance funds

24/03/2022

Under the new agreements, a number of selected CanPharma products will be included on a short-list of products that doctors will be required to prescribe to new medicinal cannabis patients affiliated with the funds.
$HHI

22/03/2022

ASX Announcement: CanPharma expands German insurance funds supply footprint. Read full announcement herehttps://wcsecure.weblink.com.au/pdf/HHI/02499500.pdf

01/03/2022

Health House International Limited has signed a binding term sheet with Zelira Therapeutics Ltd for Zelira to acquire Health House.